Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cannabis Beauty Defined is a luxury anti-aging skincare line developed by Medical Marijuana, Inc. and marketed through its subsidiary, Kannaway. The product line features hemp-derived cannabidiol (CBD) combined with "Bi-Bong" herbal formulations, which are proprietary blends of East Asian botanical extracts. The mechanism of action centers on the interaction of CBD with the endocannabinoid system (ECS) receptors in the skin, specifically CB1 and CB2, to provide antioxidant, anti-inflammatory, and sebum-regulating effects. It is primarily indicated for skin rejuvenation, reducing the appearance of fine lines and wrinkles, and improving overall skin texture and tone. The formulation is designed to leverage the synergistic effects of cannabinoids and traditional herbal medicine to enhance the skin's natural barrier and promote cellular health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cannabis Beauty Defined.